Pacira BioSciences Inc.

NASDAQ: PCRX · Real-Time Price · USD
24.88
-0.11 (-0.44%)
At close: Aug 15, 2025, 11:54 AM

Pacira BioSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-99.56M 41.95M 15.91M 41.98M
Depreciation & Amortization
78.78M 75.57M 91.5M 28.55M
Stock-Based Compensation
51.17M 47.9M 48.09M 42.25M
Other Working Capital
7.07M -31.24M -23.11M 6.49M
Other Non-Cash Items
156.89M 19.39M 14.15M 20.75M
Deferred Income Tax
20.62M 15.62M -7.95M 10.87M
Change in Working Capital
n/a -45.78M -16.43M -18.67M
Operating Cash Flow
189.39M 154.65M 145.27M 125.72M
Capital Expenditures
-10.64M -15.16M -30.08M -45.87M
Cash Acquisitions
n/a n/a -32M -437.23M
Purchase of Investments
-252.21M -144.37M -400.69M -611.49M
Sales Maturities Of Investments
179.57M 237.07M 237.58M 1.08B
Other Investing Acitivies
n/a n/a -32M -4M
Investing Cash Flow
-83.28M 77.54M -225.19M -20.79M
Debt Repayment
76.61M -180.76M -427.69M 363.75M
Common Stock Repurchased
-25M -106K 2.95M 2.81M
Dividend Paid
n/a n/a n/a -2.67M
Other Financial Acitivies
-34.25M -2.16M 26.17M 16.94M
Financial Cash Flow
17.36M -183.03M -401.53M 380.69M
Net Cash Flow
123.48M 49.16M -481.44M 485.62M
Free Cash Flow
178.75M 139.49M 115.2M 79.85M